QQ客服 官方微博 反馈留言

	A randomised, double-blind, phase 3 study comparing the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem for complicated intra-abdominal infections in hospitalised adults in Asia
	Qin, Xinyu; Binh Giang Tran; Kim, Min Ja; Wang, Lie; Dung Anh Nguyen; Chen, Qian; Song, Jie; Laud, Peter J.; Stone, Gregory G.; Chow, Joseph W.
刊名	INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
	2017
卷号	49期号:5
关键词	Ceftazidime/avibactam Complicated intra-abdominal infection Phase 3 Efficacy Safety Asia
ISSN号	0924-8579
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3615807
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Qin, Xinyu,Binh Giang Tran,Kim, Min Ja,et al. A randomised, double-blind, phase 3 study comparing the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem for complicated intra-abdominal infections in hospitalised adults in Asia[J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS,2017,49(5).
APA	Qin, Xinyu.,Binh Giang Tran.,Kim, Min Ja.,Wang, Lie.,Dung Anh Nguyen.,...&Chow, Joseph W..(2017).A randomised, double-blind, phase 3 study comparing the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem for complicated intra-abdominal infections in hospitalised adults in Asia.INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS,49(5).
MLA	Qin, Xinyu,et al."A randomised, double-blind, phase 3 study comparing the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem for complicated intra-abdominal infections in hospitalised adults in Asia".INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS 49.5(2017).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。